Evaluating Generative Pretrained Transformer (GPT) models for suicide risk assessment in synthetic patient journal entries.

Dan Holley¹, Brian Daly², Briana Beverly³, Blaken Wamsley³, Amanda Brooks³, Tom Zaubler³

¹Clinical Operation, NeuroFlow, Philadelphia, PA, USA. dan@neuroflow.com.

²Drexel University, Philadelphia, PA, USA.

³Clinical Operation, NeuroFlow, Philadelphia, PA, USA.

PubMed PMC DOI PDF

Abstract

Over 700,000 individuals die by suicide globally each year, with rapid progression from suicidal ideation (SI) to attempt often precluding opportunities for intervention. Digital behavioral health (DBH) platforms offer novel means of collecting SI indicators outside the clinic, but the actionable utility of these data may be limited by clinician-dependent workflows such as reviewing patients' jour…

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Create Free Account Sign In

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.